FreeObituary Robert W. Day, former president of Fred Hutchinson, dies at 87 January 12, 2018Vol.44 No.02By Gary Gilliland
Conversation with The Cancer LetterFree Hostin: Roche-Syapse programs will increase amount and depth of risk-benefit info in precision oncology January 12, 2018Vol.44 No.02By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Syapse: Roche collaboration enables us to experiment with new technology January 12, 2018Vol.44 No.02By Matthew Bin Han Ong
Free Roche funds effort by Syapse to build software for measuring outcomes in precision oncology January 12, 2018Vol.44 No.02By Matthew Bin Han Ong
Drugs & TargetsFree FDA approves Cabometyx for previously untreated advanced renal cell carcinoma January 05, 2018Vol.44 No.01
Drugs & TargetsFree FDA approves Pfizer’s Bosulif (bosutinib) for newly-diagnosed Ph+ CML January 05, 2018Vol.44 No.01
Drugs & TargetsFree FDA approves Xgeva for prevention of skeletal-related events in multiple myeloma January 05, 2018Vol.44 No.01
Drugs & TargetsFree Kisqali receives breakthrough designation for HR+/HER2- breast cancer January 05, 2018Vol.44 No.01
Drugs & TargetsFree FDA accepts sBLA, grants priority review for Adcetris January 05, 2018Vol.44 No.01
